NYSEMKT: CVMCel Sci Corp Stock Ownership - Who owns Cel Sci?
Insider buying vs selling
Have Cel Sci Corp insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Geert R. Kersten | Chief Executive Officer | 2025-03-31 | 22,786 | $0.23 | $5.24kBuy |
| Patricia B. Prichep | Chief Financial Officer | 2025-03-31 | 15,432 | $0.23 | $3.55kBuy |
| Eyal Talor | Chief Scientific Officer | 2025-03-31 | 10,416 | $0.23 | $2.40kBuy |
| Patricia B. Prichep | Chief Financial Operations | 2024-12-31 | 10,727 | $0.40 | $4.29kBuy |
| Geert R. Kersten | CEO | 2024-12-31 | 12,940 | $0.40 | $5.18kBuy |
| Eyal Talor | Chief Scientific Officer | 2024-12-31 | 6,001 | $0.40 | $2.40kBuy |
| Eyal Talor | Chief Scientific Officer | 2024-09-30 | 2,264 | $1.06 | $2.40kBuy |
| Geert R. Kersten | Chief Executive Officer | 2024-09-30 | 4,882 | $1.06 | $5.17kBuy |
| Patricia B. Prichep | Sr. VP of Operations | 2024-09-30 | 4,047 | $1.06 | $4.29kBuy |
| Geert R. Kersten | Chief Executive Officer | 2024-06-28 | 4,461 | $1.16 | $5.17kBuy |
CVM insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CVM insiders and whales buy or sell their stock.
CVM Shareholders
What type of owners hold Cel Sci Corp stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Geert R. Kersten | 666.60% | 20,228,410 | $45.51M | Insider |
| Vanguard Group Inc | 77.54% | 2,353,089 | $5.29M | Institution |
| Gwn Securities Inc | 39.25% | 1,191,177 | $2.68M | Institution |
| Blackrock Inc | 26.11% | 792,475 | $1.78M | Institution |
| Geode Capital Management LLC | 24.81% | 752,899 | $1.69M | Institution |
| Clara Maximilian De | 22.25% | 675,123 | $1.52M | Insider |
| Mai Capital Management | 17.35% | 526,480 | $1.18M | Institution |
| C. Richard Kinsolving | 9.96% | 302,247 | $680.06k | Insider |
| Osaic Holdings Inc | 9.53% | 289,093 | $650.46k | Institution |
| Patricia B. Prichep | 8.77% | 266,230 | $599.02k | Insider |
CVM vs Biotech Stocks
Cel Sci Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.